Sam Banister - The Art and Science of Designing Novel Psychoactive Therapeutics
Human 3 with Brom and Sam
00:00
Silo - What's Next?
Samwell is the founder and chief executive of biotech firm silo. The company has created a library of more than 1,000 compounds that could be used to develop new drugs. Silo's first set of compounds have been sent to collaborators at nita for testing. They are also working with government scientists on whether they can induce neuro plasticity in patients.
Play episode from 58:31
Transcript
